Activation of Epidermal Toll-Like Receptor 2 Enhances Tight Junction Function: Implications for Atopic Dermatitis and Skin Barrier Repair
I‐Hsin Kuo(University of Rochester Medicine), Lisa A. Beck(University of Rochester Medicine), Donald Y.M. Leung(Boston Children's Hospital), Andrew W. Borkowski, Amanda B. Carpenter-Mendini(University of Rochester Medicine), Andrei I. Ivanov(Cleveland Clinic), Richard L. Gallo(University of California San Diego), Anna De Benedetto(University of Rochester Medicine), Steve N. Georas(University of Rochester Medicine), Takeshi Yoshida(University of Rochester Medicine), Kathleen C. Barnes(Johns Hopkins University), Laura Y. McGirt(Johns Hopkins University), Kenshi Yamasaki(Tohoku University)
Cited by 171
Related Papers
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
|The Journal of Clinical Endocrinology & Metabolism|2010|4k
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k